Format

Send to

Choose Destination
J Allergy Clin Immunol. 2015 Jan;135(1):290-1. doi: 10.1016/j.jaci.2014.09.037. Epub 2014 Nov 11.

β₂-Agonist therapy may contribute to the air pollution and IL-6-associated risk of developing severe asthma with dual-positive TH2/TH17 cells.

Author information

1
Division of Allergy and Immunology, Northwestern University, Chicago, Ill.
2
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, Ill.
3
Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Ill. Electronic address: gmutlu@uchicago.edu.

Comment in

PMID:
25445822
PMCID:
PMC4386576
DOI:
10.1016/j.jaci.2014.09.037
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center